Au Rx

AuRx Inc. is a privately held biotechnology company based in Glen Burnie, Maryland, focused on developing innovative treatments for viral infections. The company gained tentative approval from the Mexican Ministry of Health to conduct a Phase 3 trial for Theraherp, a recombinant therapy aimed at suppressing genital herpes symptoms and lesions.

Theraherp, also known as ICP10 PK, demonstrated promising results in earlier clinical trials, where it notably eliminated recurrences of lesions in 84 vaccinated patients over a year. The ongoing Phase 3 trial aims to confirm the previous findings and establish the efficacy of Theraherp compared to existing treatments in the market.

Generated from the website